MedPath

CSPC Innovation Pharmaceutical Co.,Ltd.

🇨🇳China
Ownership
-
Established
2006-04-05
Employees
867
Market Cap
-
Website
http://www.xnwpharma.net
Introduction

The company was founded in 2006 and is a wholly-owned subsidiary of Hong Kong Hang Seng Index Stock Pharmaceutical Group. In 2019, Shiyao Innovation registered on the A-share GEM and became the first share of a Chinese red chip company to split back to A. The company's main business is R&D, production and sales of functional ingredients, health foods, and specialty foods. The main products are functional raw materials, mainly caffeine, acarbose, anhydrous glucose, etc. Health foods are mainly Guowekang vitamin C tablets and B vitamin tablets. The company has received honors such as the Hebei Enterprise Technology Center, the Hebei Science and Technology Achievement Award, and the 2018 Hebei Patent Award Excellence Award.

© Copyright 2025. All Rights Reserved by MedPath